Purity >80% by SDS-PAGE and Coomassie blue staining. MW (theoretical): 29 kDa. The CEP290 Recombinant Protein Antigen from Novus Biologicals is derived from E. coli. The CEP290 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.
Size
100 ul
Concentration
n/a
Applications
Antibody Competition
Other Names
BBS14Bardet-Biedl syndrome 14 protein, Cancer/testis antigen 87, centrosomal protein 290kDa, Cep290, CT87JBTS6, FLJ13615, JBTS5CTCL tumor antigen se2-2, KIAA0373FLJ21979, LCA10monoclonal 3H11 antigen, MKS4, Nephrocystin-6, NPHP6centrosomal protein of 290 kDa, POC3, POC3 centriolar protein homolog, prostate cancer antigen T21, rd16,3H11AG, SLSN6nephrocytsin-6,3H11Ag, Tumor antigen se2-2